SCHEMBL19110010

SCHEMBL19110010

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5ccc6c(c5)oc5ccc7ccc8sc9ccccc9c8c7c56)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.33
HCRTR1 O43613 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
CYP1A2 P05177 2/20 0.31
F9 P00740 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
HSD17B1 P14061 1/20 0.31
CYP2B6 P20813 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B2 P37059 1/20 0.31
CYP1A1 P04798 1/20 0.31
FYN P06241 1/20 0.31
MAPK3 P27361 1/20 0.31
AHR P35869 1/20 0.31
PAX8 Q06710 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19108787 0.97 CYP1A1 (0.33) PGRESR2CYP1A2CYP1A1FYN
SCHEMBL26492283 0.95 PGR (0.37) PGRHCRTR1ESR1ESR2CYP1A2
SCHEMBL24341820 0.95 PGR (0.35) PGRHCRTR1ESR1ESR2CYP1A2
SCHEMBL19108858 0.95 CYP1A1 (0.32) PGRESR1ESR2CYP1A2CYP1A1
SCHEMBL24342955 0.94 HCRTR1 (0.32) PGRHCRTR1ESR1ESR2CYP1A1
SCHEMBL17945779 0.92 HCRTR1 (0.33) PGRHCRTR1ESR1ESR2CYP1A1
SCHEMBL17945671 0.91 LIMK1 (0.34) PGRESR2F9MEN1POLB
SCHEMBL18268669 0.90 PGR (0.35) PGRESR1ESR2CYP1A2F9
SCHEMBL24342910 0.89 F9 (0.32) CYP1A2F9CYP1A1FYNMAPK3
SCHEMBL19110052 0.89 S1PR5 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 PGR 1328/4885HCRTR1 200/4885ESR1 153/4885
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 PGR 1328/4885HCRTR1 200/4885ESR1 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.